Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CTNNB1 |
Variant | L31_S33del |
Impact List | deletion |
Protein Effect | unknown |
Gene Variant Descriptions | CTNNB1 L31_S33del results in the deletion of three amino acids in the ubiquitination recognition motif of the Ctnnb1 protein from amino acids 31 to 33 (PMID: 15064718). L31_S33del has not been characterized in the scientific literature and therefore, its effect on Ctnnb1 protein function is unknown (PubMed, Jul 2024). |
Associated Drug Resistance | |
Category Variants Paths |
CTNNB1 mutant CTNNB1 L31_S33del |
Transcript | NM_001098210.2 |
gDNA | chr3:g.41224603_41224611delCTGGACTCT |
cDNA | c.91_99delCTGGACTCT |
Protein | p.L31_S33delLDS |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_047447479.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
NM_001330729.2 | chr3:g.41224624_41224632delGGTGCCACT | c.91_99delGGTGCCACT | p.G31_T33delGAT | RefSeq | GRCh38/hg38 |
XM_006712985.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
NM_001098209.2 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
NM_001098209.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_047447483.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_024453356.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
NM_001098210.2 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_047447482.1 | chr3:g.41224624_41224632delGGTGCCACT | c.91_99delGGTGCCACT | p.G31_T33delGAT | RefSeq | GRCh38/hg38 |
NM_001098210.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_017005738.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_047447477.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_017005738.2 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_024453357.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_024453356.2 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_047447480.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
NM_001904.4 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_047447481.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
XM_024453358.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_047447478.1 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
NM_001904.3 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33del | RefSeq | GRCh38/hg38 |
XM_006712985.2 | chr3:g.41224603_41224611delCTGGACTCT | c.91_99delCTGGACTCT | p.L31_S33delLDS | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|